With an agreement in place for Jorge Polanco to return to Seattle for the 2025 season, the Mariners’ roster is effectively set going into Dan Wilson’s first spring training as the club’s manager.

A phase 3 trial is evaluating ASP-1929 photoimmunotherapy plus Keytruda in first-line treatment for recurrent head and neck ...

"In the context of the outbreak in parts of Africa, we expect to see the occasional imported case of clade Ib mpox in the UK, ...

Drug manufacturer Novo Nordisk's amycretin, an experimental weight-loss pill in clinical trials, may boast substantial weight ...

As global markets continue to march toward record highs, driven by optimism around tariffs and AI developments, investors are increasingly looking for opportunities in smaller-cap stocks. Penny stocks ...

Welcome to the AbbVie fourth-quarter 2024 Earnings Conference Call. [Operator instructions] Today's call is also being recorded. If you have any objections, you may disconnect at this time. I would ...

The Mariners' roster is effectively set with the return of Jorge Polanco. Here's what it means for Seattle's infield mix.

South San Francisco, CA, January 30, 2025 – The California Institute for Regenerative Medicine (CIRM), one of the world’s largest institutions dedicated to regenerative medicine, has awarded nearly ...

Kearl targets production exceeding 280,000 barrels per day in 2025, with ongoing efforts to surpass 300,000 barrels per day over the next few years. The renewable diesel project at Strathcona remains ...

Elicio Therapeutics aims for breakthrough treatment with ELI-002 in pancreatic cancer. Find out why ELTX stock may benefit ...

These names in the biotech sector are seeing a substantial increase in search activity today, as determined by InvestingChannel. They ...

In the first serious fallout from President Donald Trump's early actions against offshore wind power, oil and gas giant Shell ...